🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
17.42
+0.20 (1.16%)
At close: Nov 20, 2026, 4:00 PM EST
17.18
-0.24 (-1.38%)
After-hours: Nov 20, 2026, 7:44 PM EST

Carlsmed Statistics

Total Valuation

Carlsmed has a market cap or net worth of $477.38 million. The enterprise value is $418.96 million.

Market Cap477.38M
Enterprise Value 418.96M

Important Dates

The last earnings date was Tuesday, November 10, 2026, after market close.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

Carlsmed has 27.40 million shares outstanding. The number of shares has increased by 215.17% in one year.

Current Share Class 27.40M
Shares Outstanding 27.40M
Shares Change (YoY) +215.17%
Shares Change (QoQ) +0.41%
Owned by Insiders (%) 12.17%
Owned by Institutions (%) 27.51%
Float 15.75M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.65
Forward PS 4.56
PB Ratio 6.30
P/TBV Ratio 6.31
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.84
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.79, with a Debt / Equity ratio of 0.29.

Current Ratio 5.79
Quick Ratio 5.32
Debt / Equity 0.29
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -33.33

Financial Efficiency

Return on equity (ROE) is -43.95% and return on invested capital (ROIC) is -23.86%.

Return on Equity (ROE) -43.95%
Return on Assets (ROA) -32.03%
Return on Invested Capital (ROIC) -23.86%
Return on Capital Employed (ROCE) -43.63%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee $565,157
Profits Per Employee -$315,465
Employee Count127
Asset Turnover 0.57
Inventory Turnover 7.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +47.13% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +47.13%
50-Day Moving Average 15.20
200-Day Moving Average 12.68
Relative Strength Index (RSI) 57.92
Average Volume (20 Days) 176,420

Short Selling Information

The latest short interest is 1.24 million, so 4.53% of the outstanding shares have been sold short.

Short Interest 1.24M
Short Previous Month 1.09M
Short % of Shares Out 4.53%
Short % of Float 7.88%
Short Ratio (days to cover) 15.13

Income Statement

In the last 12 months, Carlsmed had revenue of $71.78 million and -$40.06 million in losses. Loss per share was -$1.48.

Revenue71.78M
Gross Profit 55.24M
Operating Income -42.33M
Pretax Income -40.06M
Net Income -40.06M
EBITDA -41.88M
EBIT -42.33M
Loss Per Share -$1.48
Full Income Statement

Balance Sheet

The company has $80.21 million in cash and $21.79 million in debt, with a net cash position of $58.42 million or $2.13 per share.

Cash & Cash Equivalents 80.21M
Total Debt 21.79M
Net Cash 58.42M
Net Cash Per Share $2.13
Equity (Book Value) 75.67M
Book Value Per Share 2.76
Working Capital 87.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$34.36 million and capital expenditures -$556,000, giving a free cash flow of -$34.92 million.

Operating Cash Flow -34.36M
Capital Expenditures -556,000
Depreciation & Amortization 453,000
Net Borrowing n/a
Free Cash Flow -34.92M
FCF Per Share -$1.27
Full Cash Flow Statement

Margins

Gross margin is 76.96%, with operating and profit margins of -58.98% and -55.82%.

Gross Margin 76.96%
Operating Margin -58.98%
Pretax Margin -55.82%
Profit Margin -55.82%
EBITDA Margin -58.35%
EBIT Margin -58.98%
FCF Margin n/a

Dividends & Yields

Carlsmed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -215.17%
Shareholder Yield -215.17%
Earnings Yield -8.51%
FCF Yield -7.31%

Analyst Forecast

The average price target for Carlsmed is $22.00, which is 26.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.00
Price Target Difference 26.29%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) 45.14%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Carlsmed has an Altman Z-Score of 3.79 and a Piotroski F-Score of 3.

Altman Z-Score 3.79
Piotroski F-Score 3